Bloomberg Interview - Shire To Expand In Regenerative Medicine, CEO Says

October 20, 2011

Angus Russell, chief executive officer of Shire Plc, a maker of drugs for rare genetic diseases, talks about the company's acquisition strategy. He spoke yesterday with Bloomberg's Kristen Hallam in London. (Source: Bloomberg)

Clink here to watch the interview.